Skip to main content
Top
Published in: Endocrine 1/2013

01-08-2013 | Original Article

Evaluation of protein oxidation and its association with lipid peroxidation and thyrotropin levels in overt and subclinical hypothyroidism

Authors: A. Haribabu, V. Seshadri Reddy, Ch. Pallavi, Aparna R. Bitla, Alok Sachan, P. Pullaiah, V. Suresh, P. V. L. N. Srinivasa Rao, M. M. Suchitra

Published in: Endocrine | Issue 1/2013

Login to get access

Abstract

Both overt (OHT) and subclinical hypothyroid (SHT) disorders have been found to be associated with increased oxidative stress (OXS). Excess thyrotropin [thyroid stimulating hormone (TSH)] is known to directly produce OXS. Increased lipid peroxidation is known to facilitate protein carbonylation. However, the associations between lipid and protein oxidation and elevated TSH levels have not been studied. Thyroid profile, lipid peroxidation as malondialdehyde (MDA) levels and protein carbonylation as protein carbonyls (PCO) were estimated in OHT and SHT groups consisting of 36 patients each, in comparison to 39 euthyroid controls. We also determined the associations between TSH, MDA, and PCO levels in OHT and SHT groups. Increased oxidative damage was evidenced through significant elevations in the concentrations of MDA and PCO in OHT and SHT groups compared to controls (p < 0.01). Both TSH and MDA levels were positively associated with PCO in OHT group. Partial correlation analysis revealed that both excess TSH and increased MDA levels are mutually influencing elevated PCO. The results indicate that there is a simultaneous oxidative damage to lipids and proteins leading to increased MDA and PCO levels in both patient groups. Either of the excess TSH and increased MDA levels are combinably involved in the elevation of PCO in hypothyroidism.
Literature
1.
go back to reference M. Valko, D. Leibfritz, J. Moncol, M.T. Cronin, M. Mazur, J. Telser, Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39, 44–84 (2007)PubMedCrossRef M. Valko, D. Leibfritz, J. Moncol, M.T. Cronin, M. Mazur, J. Telser, Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39, 44–84 (2007)PubMedCrossRef
2.
go back to reference A.N. Torun, S. Kulaksizoglu, M. Kulaksizoglu, B.O. Pamuk, E. Isbilen, N.B. Tutuncu, Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism. Clin. Endocrinol. 70, 469–474 (2009)CrossRef A.N. Torun, S. Kulaksizoglu, M. Kulaksizoglu, B.O. Pamuk, E. Isbilen, N.B. Tutuncu, Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism. Clin. Endocrinol. 70, 469–474 (2009)CrossRef
3.
go back to reference G. Da Xiang, L.W. Xiang, H.L. He, L.S. Zhao, Post prandial lipaemia suppresses endothelium-dependent arterial dilation in patients with hypothyroidism. Endocrine 42, 391–398 (2012)PubMedCrossRef G. Da Xiang, L.W. Xiang, H.L. He, L.S. Zhao, Post prandial lipaemia suppresses endothelium-dependent arterial dilation in patients with hypothyroidism. Endocrine 42, 391–398 (2012)PubMedCrossRef
4.
go back to reference N. Nanda, Z. Bobby, A. Hamide, Association of thyroid stimulating hormone and coronary lipid risk factors with lipid peroxidation in hypothyroidism. Clin. Chem. Lab. Med. 46, 674–679 (2008)PubMedCrossRef N. Nanda, Z. Bobby, A. Hamide, Association of thyroid stimulating hormone and coronary lipid risk factors with lipid peroxidation in hypothyroidism. Clin. Chem. Lab. Med. 46, 674–679 (2008)PubMedCrossRef
5.
go back to reference L. Kebapcilar, B. Akinci, F. Bayraktar, A. Comlekci, A. Solak, T. Demir, S. Yener, T. Kume, S. Yesil, Plasma thiobarbituric acid-reactive substance levels in subclinical hypothyroidism. Med. Princ. Pract. 16, 432–436 (2007)PubMedCrossRef L. Kebapcilar, B. Akinci, F. Bayraktar, A. Comlekci, A. Solak, T. Demir, S. Yener, T. Kume, S. Yesil, Plasma thiobarbituric acid-reactive substance levels in subclinical hypothyroidism. Med. Princ. Pract. 16, 432–436 (2007)PubMedCrossRef
6.
go back to reference A. Dardano, L. Ghiadoni, Y. Plantinga, N. Caraccio, A. Bemi, E. Duranti, S. Taddei, E. Ferrannini, A. Salvetti, F. Monzani, Recombinant human TSH reduces endothelium dependent vasodilation in patients monitored for differentiated thyroid carcinoma. J. Clin. Endocrinol. Metab. 91, 4175–4178 (2006)PubMedCrossRef A. Dardano, L. Ghiadoni, Y. Plantinga, N. Caraccio, A. Bemi, E. Duranti, S. Taddei, E. Ferrannini, A. Salvetti, F. Monzani, Recombinant human TSH reduces endothelium dependent vasodilation in patients monitored for differentiated thyroid carcinoma. J. Clin. Endocrinol. Metab. 91, 4175–4178 (2006)PubMedCrossRef
7.
go back to reference I. Kowalska, J. Borawski, A.S. Nikolajuk, T. Budlewski, E. Otziomek, M. Gorska, M. Straczkowski, Insulin sensitivity, plasma adiponectin and sICAM-1 in patients with subclinical hypothyroidism: response to levothyroxine therapy. Endocrine 40, 95–101 (2011)PubMedCrossRef I. Kowalska, J. Borawski, A.S. Nikolajuk, T. Budlewski, E. Otziomek, M. Gorska, M. Straczkowski, Insulin sensitivity, plasma adiponectin and sICAM-1 in patients with subclinical hypothyroidism: response to levothyroxine therapy. Endocrine 40, 95–101 (2011)PubMedCrossRef
9.
go back to reference P.A. Grimsrud, H. Xie, T.J. Griffin, D.A. Bernlohr, Oxidative stress and covalent modification of protein with bioactive aldehydes. J. Biol. Chem. 283, 21837–21841 (2008)PubMedCrossRef P.A. Grimsrud, H. Xie, T.J. Griffin, D.A. Bernlohr, Oxidative stress and covalent modification of protein with bioactive aldehydes. J. Biol. Chem. 283, 21837–21841 (2008)PubMedCrossRef
10.
go back to reference I. Dalle-Donne, R. Rossi, D. Giustarini, A. Milzani, R. Colombo, Protein carbonyl groups as biomarkers of oxidative stress. Clin. Chim. Acta 329, 23–38 (2003)PubMedCrossRef I. Dalle-Donne, R. Rossi, D. Giustarini, A. Milzani, R. Colombo, Protein carbonyl groups as biomarkers of oxidative stress. Clin. Chim. Acta 329, 23–38 (2003)PubMedCrossRef
11.
go back to reference R. Ahmad, A.K. Tripathi, P. Tripathi, S. Singh, R. Singh, R.K. Singh, Malondialdehyde and protein carbonyl as biomarkers for oxidative stress and disease progression in patients with chronic myeloid leukemia. In Vivo 22, 525–528 (2008)PubMed R. Ahmad, A.K. Tripathi, P. Tripathi, S. Singh, R. Singh, R.K. Singh, Malondialdehyde and protein carbonyl as biomarkers for oxidative stress and disease progression in patients with chronic myeloid leukemia. In Vivo 22, 525–528 (2008)PubMed
12.
go back to reference P. Sangeetha, U. Das, R. Koratkar, P. Suryaprabha, Increase in free radical generation and lipid peroxidation following chemotherapy in patients with cancer. Free Radic. Biol. Med. 8, 15–19 (1990)PubMedCrossRef P. Sangeetha, U. Das, R. Koratkar, P. Suryaprabha, Increase in free radical generation and lipid peroxidation following chemotherapy in patients with cancer. Free Radic. Biol. Med. 8, 15–19 (1990)PubMedCrossRef
13.
go back to reference R.L. Levine, J. William, E.R. Stadtman, E. Shacter, Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol. 233, 346–357 (1994)PubMedCrossRef R.L. Levine, J. William, E.R. Stadtman, E. Shacter, Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol. 233, 346–357 (1994)PubMedCrossRef
14.
go back to reference N. Nanda, Z. Bobby, A. Hamide, Oxidative stress and protein glycation in primary hypothyroidism. Male/female difference. Clin. Exp. Med. 8, 101–108 (2008)PubMedCrossRef N. Nanda, Z. Bobby, A. Hamide, Oxidative stress and protein glycation in primary hypothyroidism. Male/female difference. Clin. Exp. Med. 8, 101–108 (2008)PubMedCrossRef
15.
go back to reference N. Nanda, Z. Bobby, A. Hamide, B.C. Koner, M.G. Sridhar, Association between oxidative stress and coronary lipid risk factors in hypothyroid women is independent of body mass index. Metabolism 56, 1350–1355 (2007)PubMedCrossRef N. Nanda, Z. Bobby, A. Hamide, B.C. Koner, M.G. Sridhar, Association between oxidative stress and coronary lipid risk factors in hypothyroid women is independent of body mass index. Metabolism 56, 1350–1355 (2007)PubMedCrossRef
16.
go back to reference B. Pereira, L.F. Rosa, D.A. Safi, E.J. Bechara, R. Curi, Control of superoxide dismutase, catalase and glutathione peroxidase activities in rat lymphoid organs by thyroid hormones. J. Endocrinol. 140, 73–77 (1994)PubMedCrossRef B. Pereira, L.F. Rosa, D.A. Safi, E.J. Bechara, R. Curi, Control of superoxide dismutase, catalase and glutathione peroxidase activities in rat lymphoid organs by thyroid hormones. J. Endocrinol. 140, 73–77 (1994)PubMedCrossRef
17.
go back to reference A. Santi, M.M. Duarte, R.N. Moresco, C. Menezes, M.D. Bagatini, M.R. Schetinger, V.L. Loro, Association between thyroid hormones, lipids and oxidative stress biomarkers in overt hypothyroidism. Clin. Chem. Lab. Med. 48, 1635–1639 (2010)PubMedCrossRef A. Santi, M.M. Duarte, R.N. Moresco, C. Menezes, M.D. Bagatini, M.R. Schetinger, V.L. Loro, Association between thyroid hormones, lipids and oxidative stress biomarkers in overt hypothyroidism. Clin. Chem. Lab. Med. 48, 1635–1639 (2010)PubMedCrossRef
18.
go back to reference A.G. Dagre, J.P. Lekakis, T.G. Papaioannou, C.M. Papamichael, D.A. Koutras, S.F. Stamatelopoulos, M. Alevizaki, Arterial stiffness is increased in subjects with hypothyroidism. Int. J. Cardiol. 103, 1–6 (2005)PubMedCrossRef A.G. Dagre, J.P. Lekakis, T.G. Papaioannou, C.M. Papamichael, D.A. Koutras, S.F. Stamatelopoulos, M. Alevizaki, Arterial stiffness is increased in subjects with hypothyroidism. Int. J. Cardiol. 103, 1–6 (2005)PubMedCrossRef
19.
go back to reference D. Donnini, F.S. Ambesi-Impiombato, F. Curcio, Thyroid stimulating hormone stimulates production of procoagulant and vasodilatative factors in human aortic endothelial cells. Thyroid 13, 517–521 (2003)PubMedCrossRef D. Donnini, F.S. Ambesi-Impiombato, F. Curcio, Thyroid stimulating hormone stimulates production of procoagulant and vasodilatative factors in human aortic endothelial cells. Thyroid 13, 517–521 (2003)PubMedCrossRef
20.
go back to reference E.F. Kershaw, J.S. Flier, Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 89, 2548–2556 (2004)PubMedCrossRef E.F. Kershaw, J.S. Flier, Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 89, 2548–2556 (2004)PubMedCrossRef
21.
go back to reference J.P. Coutlier, J.H. Kehrl, S.S. Bellur, L.D. Kohn, A.L. Notkins, B.S. Prabhakar, Binding and functional effects of thyroid stimulating hormone on human immune cells. J. Clin. Immunol. 10, 204–210 (1990)CrossRef J.P. Coutlier, J.H. Kehrl, S.S. Bellur, L.D. Kohn, A.L. Notkins, B.S. Prabhakar, Binding and functional effects of thyroid stimulating hormone on human immune cells. J. Clin. Immunol. 10, 204–210 (1990)CrossRef
22.
go back to reference G. Mazziotti, F. Sorvillo, M. Piscopo, M. Lioffi, P. Pilla, B. Biondi, S. Lorio, A. Giustina, G. Amato, C. Carella, Recombinant human TSH modulates in vivo C-telopeptides of type-I collagen and bone alkaline phosphatase, but not osteoprotegerin production in post menopausal women monitored for diffrentiated thyroid carcinoma. J. Bone Miner. Res. 20, 480–486 (2005)PubMedCrossRef G. Mazziotti, F. Sorvillo, M. Piscopo, M. Lioffi, P. Pilla, B. Biondi, S. Lorio, A. Giustina, G. Amato, C. Carella, Recombinant human TSH modulates in vivo C-telopeptides of type-I collagen and bone alkaline phosphatase, but not osteoprotegerin production in post menopausal women monitored for diffrentiated thyroid carcinoma. J. Bone Miner. Res. 20, 480–486 (2005)PubMedCrossRef
23.
go back to reference G. Mazziotti, T. Porcelli, I. Patelli, P.P. Vescovi, A. Giustina, Serum TSH values and risk of vertebral fractures in euthyroid post menopausal women with low mineral density. Bone 46(3), 747–751 (2010)PubMedCrossRef G. Mazziotti, T. Porcelli, I. Patelli, P.P. Vescovi, A. Giustina, Serum TSH values and risk of vertebral fractures in euthyroid post menopausal women with low mineral density. Bone 46(3), 747–751 (2010)PubMedCrossRef
24.
go back to reference M. Mark, P.J. Vanderpump, W. Michael, G. Tunbridge, How the Doctor Finds Out What is Wrong, in Thyroid Disease the Facts, 4th edn., ed. by M. Mark, P.J. Vanderpump, W. Michael, G. Tunbridge (Oxford University Press, New York, 2008), pp. 15–17 M. Mark, P.J. Vanderpump, W. Michael, G. Tunbridge, How the Doctor Finds Out What is Wrong, in Thyroid Disease the Facts, 4th edn., ed. by M. Mark, P.J. Vanderpump, W. Michael, G. Tunbridge (Oxford University Press, New York, 2008), pp. 15–17
Metadata
Title
Evaluation of protein oxidation and its association with lipid peroxidation and thyrotropin levels in overt and subclinical hypothyroidism
Authors
A. Haribabu
V. Seshadri Reddy
Ch. Pallavi
Aparna R. Bitla
Alok Sachan
P. Pullaiah
V. Suresh
P. V. L. N. Srinivasa Rao
M. M. Suchitra
Publication date
01-08-2013
Publisher
Springer US
Published in
Endocrine / Issue 1/2013
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-012-9849-y

Other articles of this Issue 1/2013

Endocrine 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine